The presence of genetic abnormalities in genes related to the development of myeloid neoplasms in aging population (e.g., JAK2, DNMT3, TET2, and ASXL1) [37] is associated with increased risk of hematologic malignancies, all-cause mortality, and cardiovascular disease [37, 38]. This evidence concerns the gene JAK2 and hematologic disorder.